−0.30USD
−66.07 MUSD
124.46 MUSD
223.69 M
About Ardelyx, Inc.
Sector
CEO
Michael G. Raab
Headquarters
Waltham
Website
Employees (FY)
267
Founded
2007
ISIN
US0396971071
FIGI
BBG001WH4DQ3
Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ARDX is 6.55 USD — it has decreased by 2.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ardelyx, Inc. stocks are traded under the ticker ARDX.
Ardelyx, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Ardelyx, Inc. has a max estimate of 16.00 USD and a min estimate of 11.00 USD.
ARDX earnings for the last quarter are 0.03 USD whereas the estimation was −0.11 USD which accounts for 127.89% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Ardelyx, Inc. earnings.
Ardelyx, Inc. revenue for the last quarter amounts to 56.39 M USD despite the estimated figure of 22.57 M USD. In the next quarter revenue is expected to reach 34.06 M USD.
Yes, you can track Ardelyx, Inc. financials in yearly and quarterly reports right on TradingView.
ARDX stock has fallen by 5.21% compared to the previous week, the month change is a 19.24% fall, over the last year Ardelyx, Inc. has showed a 29.96% increase.
Like other stocks, ARDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ardelyx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 267.00 employees. See our rating of the largest employees — is Ardelyx, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ardelyx, Inc. EBITDA is −59.29 M USD, and current EBITDA margin is −49.80%. See more stats in Ardelyx, Inc. financial statements.